{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:53:10Z","timestamp":1764172390872,"version":"3.37.3"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11102-020-01052-0","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T16:23:15Z","timestamp":1591201395000},"page":"432-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["GH deficiency in cancer survivors in the transition age: diagnosis and therapy"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-9783","authenticated-orcid":false,"given":"Emilia","family":"Sbardella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Crocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Feola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortuna","family":"Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Puliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Gianfrilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"2","key":"1052_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106\u2013130","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"1052_CR2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572\u20131582","journal-title":"N Engl J Med"},{"issue":"3","key":"1052_CR3","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1677\/ERC-10-0002","volume":"17","author":"W Chemaitilly","year":"2010","unstructured":"Chemaitilly W, Sklar CA (2010) Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer 17(3):R141\u2013R159","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1052_CR4","first-page":"65","volume":"69","author":"R Nandagopal","year":"2008","unstructured":"Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L (2008) Endocrine late effects of childhood cancer therapy: a report from the Children\u2019s Oncology Group. Horm Res 69(2):65\u201374","journal-title":"Horm Res"},{"issue":"1","key":"1052_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/humupd\/dmr038","volume":"18","author":"W van Dorp","year":"2012","unstructured":"van Dorp W, van Beek RD, Laven JS, Pieters R, de Muinck Keizer-Schrama SM, van den Heuvel-Eibrink MM (2012) Long-term endocrine side effects of childhood Hodgkin\u2019s lymphoma treatment: a review. Hum Reprod Update 18(1):12\u201328","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1052_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/PPO.0b013e3181a58f46","volume":"15","author":"S Bhatia","year":"2009","unstructured":"Bhatia S, Constine LS (2009) Late morbidity after successful treatment of children with cancer. Cancer J 15(3):174\u2013180","journal-title":"Cancer J"},{"issue":"22","key":"1052_CR7","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1200\/JCO.2011.34.6585","volume":"29","author":"GT Armstrong","year":"2011","unstructured":"Armstrong GT, Liu W, Leisenring W, Yasui Y, Hammond S, Bhatia S et al (2011) Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol Off J Am Soc Clin Oncol 29(22):3056\u20133064","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9700","key":"1052_CR8","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(09)61885-7","volume":"374","author":"KC Oeffinger","year":"2009","unstructured":"Oeffinger KC, Bhatia S (2009) Second primary cancers in survivors of childhood cancer. Lancet 374(9700):1484\u20131485","journal-title":"Lancet"},{"issue":"7","key":"1052_CR9","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/ijc.27393","volume":"131","author":"S Garwicz","year":"2012","unstructured":"Garwicz S, Anderson H, Olsen JH, Winther JF, Sankila R, Langmark F et al (2012) Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades\u2014experience from the Nordic countries. Int J Cancer 131(7):1659\u20131666","journal-title":"Int J Cancer"},{"issue":"22","key":"1052_CR10","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1001\/jama.2011.747","volume":"305","author":"RC Reulen","year":"2011","unstructured":"Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM, British Childhood Cancer Survivor Study Steering Group (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305(22):2311\u20132319","journal-title":"JAMA"},{"issue":"25","key":"1052_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.15585\/mmwr.mm6725a2","volume":"67","author":"DA Siegel","year":"2018","unstructured":"Siegel DA, Li J, Henley SJ, Wilson RJ, Lunsford NB, Tai E et al (2018) Geographic variation in pediatric cancer incidence-United States, 2003\u20132014. Morb Mortal Wkly Rep 67(25):707\u2013713","journal-title":"Morb Mortal Wkly Rep"},{"issue":"3","key":"1052_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11060-019-03321-w","volume":"145","author":"W Huang","year":"2019","unstructured":"Huang W, Sundquist J, Sundquist K, Ji J (2019) Mortality patterns in long-term survivors of childhood or adolescent central nervous system tumour in Sweden. J Neurooncol 145(3):541\u2013549","journal-title":"J Neurooncol"},{"issue":"4","key":"1052_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/EJE-16-0455","volume":"175","author":"E Sbardella","year":"2016","unstructured":"Sbardella E, Joseph RN, Jafar-Mohammadi B, Isidori AM, Cudlip S, Grossman AB (2016) Pituitary stalk thickening: the role of an innovative MRI imaging analysis which may assist in determining clinical management. Eur J Endocrinol 175(4):255\u2013263","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1052_CR14","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1210\/jc.2018-01871","volume":"104","author":"GA Kaltsas","year":"2019","unstructured":"Kaltsas GA, Kolomodi D, Randeva H, Grossman A (2019) Nonneuroendocrine neoplasms of the pituitary region. J Clin Endocrinol Metab 104(8):3108\u20133123","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1052_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s12020-016-1038-y","volume":"55","author":"G Vitale","year":"2017","unstructured":"Vitale G, Tortora F, Baldelli R, Cocchiara F, Paragliola RM, Sbardella E et al (2017) Pituitary magnetic resonance imaging in Cushing\u2019s disease. Endocrine 55(3):691\u2013696","journal-title":"Endocrine"},{"issue":"8","key":"1052_CR16","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1210\/jc.2018-01175","volume":"103","author":"CA Sklar","year":"2018","unstructured":"Sklar CA, Antal Z, Chemaitilly W, Cohen LE, Follin C, Meacham LR et al (2018) Hypothalamic\u2013pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 103(8):2761\u20132784","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1052_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1530\/EJE-12-1043","volume":"168","author":"E Brignardello","year":"2013","unstructured":"Brignardello E, Felicetti F, Castiglione A, Chiabotto P, Corrias A, Fagioli F et al (2013) Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol 168(3):465\u2013472","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1052_CR18","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1210\/jc.2019-00834","volume":"104","author":"L van Iersel","year":"2019","unstructured":"van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL et al (2019) Hypothalamic\u2013pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes. J Clin Endocrinol Metab 104(12):6101\u20136115","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1052_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/cen.13232","volume":"86","author":"E Sbardella","year":"2017","unstructured":"Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B et al (2017) Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol (Oxf) 86(2):177\u2013184","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"1052_CR20","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1210\/jc.2018-00529","volume":"103","author":"R Pofi","year":"2018","unstructured":"Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB et al (2018) The short synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function. J Clin Endocrinol Metab 103(8):3050\u20133059","journal-title":"J Clin Endocrinol Metab"},{"key":"1052_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fendo.2018.00434","volume":"9","author":"C Graziadio","year":"2018","unstructured":"Graziadio C, Hasenmajer V, Venneri MA, Gianfrilli D, Isidori AM, Sbardella E (2018) Glycometabolic alterations in secondary adrenal insufficiency: does replacement therapy play a role? Front Endocrinol (Lausanne) 9:434","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1052_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V et al (2018) Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol 6(3):173\u2013185","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1052_CR23","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1210\/jc.2018-00346","volume":"103","author":"MA Venneri","year":"2018","unstructured":"Venneri MA, Hasenmajer V, Fiore D, Sbardella E, Pofi R, Graziadio C et al (2018) Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM Trial Ancillary Study. J Clin Endocrinol Metab 103(8):2998\u20133009","journal-title":"J Clin Endocrinol Metab"},{"key":"1052_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40618-019-01146-y","volume":"43","author":"AM Isidori","year":"2019","unstructured":"Isidori AM, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R et al (2019) Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion. J Endocrinol Investig 43:683\u2013696","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"1052_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bmt.1705694","volume":"40","author":"W Chemaitilly","year":"2007","unstructured":"Chemaitilly W, Boulad F, Heller G, Kernan NA, Small TN, O\u2019Reilly RJ et al (2007) Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 40(1):29\u201335","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1052_CR26","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1210\/jc.2018-01205","volume":"103","author":"S Tamhane","year":"2018","unstructured":"Tamhane S, Sfeir JG, Kittah NEN, Jasim S, Chemaitilly W, Cohen LE et al (2018) GH therapy in childhood cancer survivors: a systematic review and meta-analysis. J Clin Endocrinol Metab 103(8):2794\u20132801","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR27","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/EJE-19-0298","volume":"181","author":"E Sbardella","year":"2019","unstructured":"Sbardella E, Pozza C, Isidori AM, Grossman AB (2019) ENDOCRINOLOGY AND ADOLESCENCE: dealing with transition in young patients with pituitary disorders. Eur J Endocrinol 181(4):R155\u2013R171","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1052_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4274\/jcrpe.v1i5.205","volume":"1","author":"ME Geffner","year":"2009","unstructured":"Geffner ME (2009) Growth hormone replacement therapy: transition from adolescence to adulthood. J Clin Res Pediatr Endocrinol 1(5):205\u2013208","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"2","key":"1052_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","volume":"87","author":"ML Hartman","year":"2002","unstructured":"Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ et al (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87(2):477\u2013485","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1052_CR30","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1210\/jc.2011-0306","volume":"96","author":"NM Appelman-Dijkstra","year":"2011","unstructured":"Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romijn JA et al (2011) Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab 96(8):2330\u20132340","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1052_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"KK Ho","year":"2007","unstructured":"Ho KK, GHDCW Participants (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157(6):695\u2013700","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1052_CR32","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1530\/EJE-16-0962","volume":"176","author":"A Garrahy","year":"2017","unstructured":"Garrahy A, Sherlock M, Thompson CJ (2017) MANAGEMENT OF ENDOCRINE DISEASE: neuroendocrine surveillance and management of neurosurgical patients. Eur J Endocrinol 176(5):R217\u2013R233","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1052_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11102-011-0372-6","volume":"15","author":"DM Cook","year":"2012","unstructured":"Cook DM, Rose SR (2012) A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 15(3):301\u2013310","journal-title":"Pituitary"},{"issue":"2","key":"1052_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/eje.1.01829","volume":"152","author":"PE Clayton","year":"2005","unstructured":"Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M et al (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 152(2):165\u2013170","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1052_CR35","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1210\/jc.2007-0167","volume":"92","author":"S Radovick","year":"2007","unstructured":"Radovick S, DiVall S (2007) Approach to the growth hormone-deficient child during transition to adulthood. J Clin Endocrinol Metab 92(4):1195\u20131200","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1210\/jcem.84.4.5614","volume":"84","author":"M Maghnie","year":"1999","unstructured":"Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S et al (1999) Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 84(4):1324\u20131328","journal-title":"J Clin Endocrinol Metab"},{"issue":"3570","key":"1052_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1126\/science.140.3570.987","volume":"140","author":"J Roth","year":"1963","unstructured":"Roth J, Glick SM, Yalow RS, Berson SA (1963) Hypoglycemia: a potent stimulus to secretion of growth hormone. Science 140(3570):987\u2013988","journal-title":"Science"},{"issue":"26","key":"1052_CR38","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","volume":"321","author":"F Salomon","year":"1989","unstructured":"Salomon F, Cuneo RC, Hesp R, Sonksen PH (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321(26):1797\u20131803","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"1052_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.15.S2.1","volume":"15","author":"DM Cook","year":"2009","unstructured":"Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML, American Association of Clinical Endocrinologists (2009) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients\u20142009 update. Endocr Pract 15(Suppl 2):1\u201329","journal-title":"Endocr Pract"},{"issue":"6","key":"1052_CR40","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine S (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(6):1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1052_CR41","first-page":"3693","volume":"85","author":"G Aimaretti","year":"2000","unstructured":"Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E et al (2000) Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. J Clin Endocrinol Metab 85(10):3693\u20133699","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1052_CR42","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1210\/jcem.86.11.8056","volume":"86","author":"L Adan","year":"2001","unstructured":"Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R (2001) GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab 86(11):5245\u20135251","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR43","first-page":"165","volume":"58","author":"C Castro","year":"2002","unstructured":"Castro C, Trivin C, Souberbielle JC, Zerah M, Brauner R (2002) Growth hormone deficiency: permanence and diagnosis in young adults. Horm Res 58(4):165\u2013171","journal-title":"Horm Res"},{"issue":"2","key":"1052_CR44","first-page":"663","volume":"86","author":"CA Lissett","year":"2001","unstructured":"Lissett CA, Saleem S, Rahim A, Brennan BM, Shalet SM (2001) The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis. J Clin Endocrinol Metab 86(2):663\u2013668","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR45","first-page":"1574","volume":"86","author":"M Maghnie","year":"2001","unstructured":"Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M et al (2001) Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 86(4):1574\u20131579","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1530\/eje.1.01873","volume":"152","author":"M Maghnie","year":"2005","unstructured":"Maghnie M, Aimaretti G, Bellone S, Bona G, Bellone J, Baldelli R et al (2005) Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur J Endocrinol 152(4):589\u2013596","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1052_CR47","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1210\/jc.2009-0602","volume":"94","author":"A Secco","year":"2009","unstructured":"Secco A, di Iorgi N, Napoli F, Calandra E, Calcagno A, Ghezzi M et al (2009) Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing. J Clin Endocrinol Metab 94(11):4195\u20134204","journal-title":"J Clin Endocrinol Metab"},{"key":"1052_CR48","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fendo.2019.00525","volume":"10","author":"G Patti","year":"2019","unstructured":"Patti G, Noli S, Capalbo D, Allegri AME, Napoli F, Cappa M et al (2019) Accuracy and limitations of the growth hormone (GH) releasing hormone-arginine retesting in young adults with childhood-onset GH deficiency. Front Endocrinol (Lausanne) 10:525","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1052_CR49","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1210\/jc.2018-01204","volume":"103","author":"JG Sfeir","year":"2018","unstructured":"Sfeir JG, Kittah NEN, Tamhane SU, Jasim S, Chemaitilly W, Cohen LE et al (2018) Diagnosis of GH deficiency as a late effect of radiotherapy in survivors of childhood cancers. J Clin Endocrinol Metab 103(8):2785\u20132793","journal-title":"J Clin Endocrinol Metab"},{"key":"1052_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000487525","volume":"33","author":"S Loche","year":"2018","unstructured":"Loche S, Di Iorgi N, Patti G, Noli S, Giaccardi M, Olivieri I et al (2018) Growth hormone deficiency in the transition age. Endocr Dev 33:46\u201356","journal-title":"Endocr Dev"},{"issue":"12","key":"1052_CR51","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1210\/jc.2014-2830","volume":"99","author":"LE Dichtel","year":"2014","unstructured":"Dichtel LE, Yuen KC, Bredella MA, Gerweck AV, Russell BM, Riccio AD et al (2014) Overweight\/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency. J Clin Endocrinol Metab 99(12):4712\u20134719","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1052_CR52","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1515\/CCLM.2011.201","volume":"49","author":"A Muller","year":"2011","unstructured":"Muller A, Scholz M, Blankenstein O, Binder G, Pfaffle R, Korner A et al (2011) Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clin Chem Lab Med 49(7):1135\u20131142","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"1052_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/EJE-14-0165","volume":"171","author":"IV Wagner","year":"2014","unstructured":"Wagner IV, Paetzold C, Gausche R, Vogel M, Koerner A, Thiery J et al (2014) Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry. Eur J Endocrinol 171(3):389\u2013397","journal-title":"Eur J Endocrinol"},{"issue":"Suppl A","key":"1052_CR54","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.ghir.2006.03.002","volume":"16","author":"KH Darzy","year":"2006","unstructured":"Darzy KH, Shalet SM (2006) Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Horm IGF Res 16(Suppl A):S30\u2013S40","journal-title":"Growth Horm IGF Res"},{"issue":"8","key":"1052_CR55","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1210\/jc.2003-030366","volume":"88","author":"HK Gleeson","year":"2003","unstructured":"Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM (2003) Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 88(8):3682\u20133689","journal-title":"J Clin Endocrinol Metab"},{"key":"1052_CR56","doi-asserted-by":"publisher","DOI":"10.1177\/2047487314529348","author":"F Felicetti","year":"2015","unstructured":"Felicetti F, D\u2019Ascenzo F, Moretti C, Corrias A, Omed\u00e8 P, Marra WG, Arvat E, Fagioli F, Brignardello E, Gaita F (2015) Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry. Eur J Prev Cardiol. https:\/\/doi.org\/10.1177\/2047487314529348","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"1052_CR57","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-2265.2008.03283.x","volume":"69","author":"M Steffens","year":"2008","unstructured":"Steffens M, Beauloye V, Brichard B, Robert A, Alexopoulou O, Vermylen Ch, Maiter D (2008) Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf) 69(5):819\u2013827","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1052_CR58","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/annonc\/mdp414","volume":"21","author":"M van Waas","year":"2010","unstructured":"van Waas M, Neggers S, Pieters R, van den Heuvel-Eibrink MM (2010) Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol 21(5):1121\u20131126","journal-title":"Ann Oncol"},{"issue":"5","key":"1052_CR59","first-page":"357","volume":"104","author":"LB Travis","year":"2014","unstructured":"Travis LB, Ng A, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr (2014) Second malignant neoplasms and cardiovascular disease following radiotherapy. Health Phys 104(5):357\u2013370","journal-title":"Health Phys"},{"issue":"9","key":"1052_CR60","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1210\/jc.2011-0112","volume":"96","author":"S Mackenzie","year":"2011","unstructured":"Mackenzie S, Craven T, Gattamaneni HR, Swindell R, Shalet SM, Brabant G (2011) Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab 96(9):2756\u20132761","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1052_CR61","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","volume":"87","author":"CA Sklar","year":"2002","unstructured":"Sklar CA, Mertens A, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87(7):3136\u20133141","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1052_CR62","first-page":"4444","volume":"85","author":"AJ Swerdlow","year":"2000","unstructured":"Swerdlow AJ, Reddingius R, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM (2000) Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 85(12):4444\u20134449","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1052_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40618-014-0179-1","volume":"38","author":"E Brignardello","year":"2015","unstructured":"Brignardello E, Felicetti F, Castiglione A, Fortunati N, Matarazzo P, Biasin E, Sacerdote C, Ricardi U, Fagioli F, Corrias A, Arvat E (2015) GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution. J Endocrinol Investig 38(2):171\u2013176","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"1052_CR64","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1530\/EJE-12-0967","volume":"168","author":"WW Woodmansee","year":"2013","unstructured":"Woodmansee WW, Zimmermann A, Child CJ, Rong Q, Erfurth EM, Beck-Peccoz P, Blum WF, Robison LL, GeNeSIS and HypoCCS International Advisory Boards (2013) Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS. Eur J Endocrinol 168(4):565\u2013573","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1052_CR65","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11102-008-0101-y","volume":"12","author":"VT Nguyen","year":"2009","unstructured":"Nguyen VT, Misra M (2009) Transitioning of children with GH deficiency to adult dosing: changes in body composition. Pituitary 12(2):125\u2013135","journal-title":"Pituitary"},{"issue":"6","key":"1052_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al (2016) Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 86(6):361\u2013397","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"1052_CR67","doi-asserted-by":"publisher","first-page":"E1191","DOI":"10.1152\/ajpendo.2001.281.6.E1191","volume":"281","author":"T Wolthers","year":"2001","unstructured":"Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M, Ho KK (2001) Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 281(6):E1191\u2013E1196","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"1052_CR68","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1651-2227.1996.tb14224.x","volume":"85","author":"L Adan","year":"1996","unstructured":"Adan L, Souberbielle JC, Blanche S, Leverger G, Schaison G, Brauner R (1996) Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta paediatr 85(9):1096\u20131101","journal-title":"Acta paediatr"},{"key":"1052_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2431-8-25","volume":"8","author":"J Huisman","year":"2008","unstructured":"Huisman J, Aukema EJ, Deijen JB, van Coeverden SC, Kaspers GJ, van der Pal HJ et al (2008) The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study. BMC Pediatr 8:25","journal-title":"BMC Pediatr"},{"issue":"2","key":"1052_CR70","first-page":"91","volume":"49","author":"DA Price","year":"1998","unstructured":"Price DA, Wilton P, Jonsson P, Albertsson-Wikland K, Chatelain P, Cutfield W et al (1998) Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 49(2):91\u201397","journal-title":"Horm Res"},{"issue":"10","key":"1052_CR71","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1210\/jc.2003-030619","volume":"88","author":"W Xu","year":"2003","unstructured":"Xu W, Janss A, Moshang T (2003) Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab 88(10):4677\u20134681","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR72","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000284393","volume":"73","author":"M Ciaccio","year":"2010","unstructured":"Ciaccio M, Gil S, Guercio G, Vaiani E, Alderete D, Palladino M et al (2010) Effectiveness of RHGH treatment on adult height in GH-deficient childhood survivors of medulloblastoma. Horm Res Paediatr 73(4):281\u2013286","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"1052_CR73","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1651-2227.1989.tb17937.x","volume":"78","author":"B Lannering","year":"1989","unstructured":"Lannering B, Albertsson-Wikland K (1989) Improved growth response to GH treatment in irradiated children. Acta paediatr Scand 78(4):562\u2013567","journal-title":"Acta paediatr Scand"},{"issue":"1","key":"1052_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1210\/jcem.87.1.8146","volume":"87","author":"RD Murray","year":"2002","unstructured":"Murray RD, Darzy KH, Gleeson HK, Shalet SM (2002) GH-deficient survivors of childhood cancer: GH replacement during adult life. J Clin Endocrinol Metab 87(1):129\u2013135","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1052_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1515\/JPEM.1997.10.1.41","volume":"10","author":"A Corrias","year":"1997","unstructured":"Corrias A, Picco P, Einaudi S, de Sanctis L, Besenzon L, Garre ML et al (1997) Growth hormone treatment in irradiated children with brain tumors. J Pediatr Endocrinol Metab 10(1):41\u201349","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"1052_CR76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2007.02930.x","volume":"67","author":"B Bakker","year":"2007","unstructured":"Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM (2007) Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clin Endocrinol (Oxf) 67(4):589\u2013597","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1052_CR77","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1530\/EJE-09-0690","volume":"162","author":"D Beckers","year":"2010","unstructured":"Beckers D, Thomas M, Jamart J, Francois I, Maes M, Lebrethon MC et al (2010) Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience. Eur J Endocrinol 162(3):483\u2013490","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1052_CR78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.bmt.1704324","volume":"33","author":"P Frisk","year":"2004","unstructured":"Frisk P, Arvidson J, Gustafsson J, Lonnerholm G (2004) Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 33(2):205\u2013210","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"1052_CR79","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1210\/jc.2004-1515","volume":"89","author":"SE Lerner","year":"2004","unstructured":"Lerner SE, Huang GJ, McMahon D, Sklar CA, Oberfield SE (2004) Growth hormone therapy in children after cranial\/craniospinal radiation therapy: sexually dimorphic outcomes. J Clin Endocrinol Metab 89(12):6100\u20136104","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"1052_CR80","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1200\/JCO.2002.09.142","volume":"20","author":"W Leung","year":"2002","unstructured":"Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA et al (2002) Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol 20(13):2959\u20132964","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"1052_CR81","first-page":"28","volume":"64","author":"MB Ranke","year":"2005","unstructured":"Ranke MB, Price DA, Lindberg A, Wilton P, Darendeliler F, Reiter EO (2005) Final height in children with medulloblastoma treated with growth hormone. Horm Res 64(1):28\u201334","journal-title":"Horm Res"},{"issue":"5","key":"1052_CR82","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000184276","volume":"43","author":"S Vassilopoulou","year":"1995","unstructured":"Vassilopoulou S, Klein MJ, Moore BD III, Reid HL, Ater J, Zietz HA (1995) Efficacy of growth hormone replacement therapy in children with organic growth hormone deficiency after cranial irradiation. Horm Res 43(5):188\u2013193","journal-title":"Horm Res"},{"issue":"4","key":"1052_CR83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/archpedi.1985.02140060029020","volume":"139","author":"SA Arslanian","year":"1985","unstructured":"Arslanian SA, Becker DJ, Lee PA, Drash AL, Foley TP Jr (1985) Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism. Am J Dis Child 139(4):347\u2013350","journal-title":"Am J Dis Child"},{"issue":"2","key":"1052_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40618-014-0179-1","volume":"38","author":"E Brignardello","year":"2015","unstructured":"Brignardello E, Felicetti F, Castiglione A, Fortunati N, Matarazzo P, Biasin E et al (2015) GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution. J Endocrinol Investig 38(2):171\u2013176","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"1052_CR85","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1080\/08035250600577889","volume":"95","author":"F Darendeliler","year":"2006","unstructured":"Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Anthony Price D et al (2006) Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta paediatr 95(10):1284\u20131290","journal-title":"Acta paediatr"},{"issue":"11","key":"1052_CR86","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/pbc.24667","volume":"60","author":"S Mostoufi-Moab","year":"2013","unstructured":"Mostoufi-Moab S, Isaacoff EJ, Spiegel D, Gruccio D, Ginsberg JP, Hobbie W et al (2013) Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy. Pediatr Blood Cancer 60(11):1766\u20131771","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1052_CR87","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1210\/jcem.87.1.8150","volume":"87","author":"P Cohen","year":"2002","unstructured":"Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG, American Norditropin Clinical Trials Group (2002) Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 87(1):90\u201398","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1052_CR88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4158\/EP13194.OR","volume":"20","author":"BK Aydin","year":"2014","unstructured":"Aydin BK, Aycan Z, Siklar Z, Berberoglu M, Ocal G, Cetinkaya S et al (2014) Adherence to growth hormone therapy: results of a multicenter study. Endocr Pract 20(1):46\u201351","journal-title":"Endocr Pract"},{"issue":"1","key":"1052_CR89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1515\/jpem-2017-0157","volume":"31","author":"S Mohseni","year":"2018","unstructured":"Mohseni S, Heydari Z, Qorbani M, Radfar M (2018) Adherence to growth hormone therapy in children and its potential barriers. J Pediatr Endocrinol Metab 31(1):13\u201320","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1052_CR90","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3389\/fendo.2019.00416","volume":"10","author":"A Mancini","year":"2019","unstructured":"Mancini A, Vergani E, Bruno C, Palladino A, Brunetti A (2019) Relevance of adherence monitoring in adult patients with growth hormone deficiency under replacement therapy: preliminary monocentric data with Easypod(TM) Connect. Front Endocrinol (Lausanne) 10:416","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1052_CR91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4158\/EP.14.2.143","volume":"14","author":"RG Rosenfeld","year":"2008","unstructured":"Rosenfeld RG, Bakker B (2008) Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 14(2):143\u2013154","journal-title":"Endocr Pract"},{"issue":"6","key":"1052_CR92","doi-asserted-by":"publisher","first-page":"601","DOI":"10.20945\/2359-3997000000190","volume":"63","author":"RA Lal","year":"2019","unstructured":"Lal RA, Hoffman AR (2019) Perspectives on long-acting growth hormone therapy in children and adults. Arch Endocrinol Metab 63(6):601\u2013607","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"1052_CR93","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1530\/EC-17-0007","volume":"6","author":"C Hoybye","year":"2017","unstructured":"Hoybye C, Pfeiffer AF, Ferone D, Christiansen JS, Gilfoyle D, Christoffersen ED et al (2017) A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency. Endocr Connect 6(3):129\u2013138","journal-title":"Endocr Connect"},{"issue":"6","key":"1052_CR94","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1530\/EJE-16-0111","volume":"174","author":"JS Christiansen","year":"2016","unstructured":"Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF et al (2016) Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol 174(6):C1\u2013C8","journal-title":"Eur J Endocrinol"},{"key":"1052_CR95","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000439333","volume":"30","author":"PH Saenger","year":"2016","unstructured":"Saenger PH, Mejia-Corletto J (2016) Long-acting growth hormone: an update. Endocr Dev 30:79\u201397","journal-title":"Endocr Dev"},{"issue":"2","key":"1052_CR96","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-15-0873","volume":"174","author":"DB Allen","year":"2016","unstructured":"Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P et al (2016) GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol 174(2):P1\u2013P9","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1052_CR97","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000284358","volume":"73","author":"HL Muller","year":"2010","unstructured":"Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A et al (2010) Analyses of treatment variables for patients with childhood craniopharyngioma\u2014results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr 73(3):175\u2013180","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"1052_CR98","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1365-2265.2006.02508.x","volume":"64","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J et al (2006) GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf) 64(5):556\u2013560","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1052_CR99","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1530\/EJE-12-0077","volume":"166","author":"DS Olsson","year":"2012","unstructured":"Olsson DS, Buchfelder M, Wiendieck K, Kremenevskaja N, Bengtsson BA, Jakobsson KE et al (2012) Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up. Eur J Endocrinol 166(6):1061\u20131068","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1052_CR100","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","volume":"63","author":"TT Chung","year":"2005","unstructured":"Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL et al (2005) Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement. Clin Endocrinol 63(3):274\u2013279","journal-title":"Clin Endocrinol"},{"issue":"5 Pt 2","key":"1052_CR101","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0022-3476(96)70002-1","volume":"128","author":"T Moshang Jr","year":"1996","unstructured":"Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A (1996) Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128(5 Pt 2):S4\u2013S7","journal-title":"J Pediatr"},{"issue":"2","key":"1052_CR102","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/jc.2017-01899","volume":"103","author":"K Krzyzanowska-Mittermayer","year":"2018","unstructured":"Krzyzanowska-Mittermayer K, Mattsson AF, Maiter D, Feldt-Rasmussen U, Camacho-Hubner C, Luger A et al (2018) New neoplasm during GH replacement in adults with pituitary deficiency following malignancy: a KIMS analysis. J Clin Endocrinol Metab 103(2):523\u2013531","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1052_CR103","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/jc.2018-01189","volume":"104","author":"CJ Child","year":"2019","unstructured":"Child CJ, Zimmermann AG, Chrousos GP, Cummings E, Deal CL, Hasegawa T et al (2019) Safety outcomes during pediatric GH therapy: final results from the Prospective GeNeSIS Observational Program. J Clin Endocrinol Metab 104(2):379\u2013389","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1052_CR104","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1210\/jc.2013-4159","volume":"99","author":"BC Patterson","year":"2014","unstructured":"Patterson BC, Chen Y, Sklar CA, Neglia J, Yasui Y, Mertens A et al (2014) Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 99(6):2030\u20132037","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1052_CR105","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-14-1123","volume":"172","author":"CJ Child","year":"2015","unstructured":"Child CJ, Conroy D, Zimmermann AG, Woodmansee WW, Erfurth EM, Robison LL (2015) Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study. Eur J Endocrinol 172(6):779\u2013790","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1052_CR106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/00024677-200605040-00005","volume":"5","author":"JB Deijen","year":"2006","unstructured":"Deijen JB, Arwert LI (2006) Impaired quality of life in hypopituitary adults with growth hormone deficiency: can somatropin replacement therapy help? Treat Endocrinol 5(4):243\u2013250","journal-title":"Treat Endocrinol"},{"issue":"3","key":"1052_CR107","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1210\/jc.2004-0832","volume":"90","author":"A Mukherjee","year":"2005","unstructured":"Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (2005) The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab 90(3):1542\u20131549","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1052_CR108","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1008987922774","volume":"8","author":"SP McKenna","year":"1999","unstructured":"McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L et al (1999) The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 8(4):373\u2013383","journal-title":"Qual Life Res"},{"issue":"8","key":"1052_CR109","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1210\/jc.2010-0117","volume":"95","author":"C Follin","year":"2010","unstructured":"Follin C, Thilen U, Osterberg K, Bjork J, Erfurth EM (2010) Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 95(8):3726\u20133735","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"1052_CR110","first-page":"97","volume":"25","author":"HL Fideleff","year":"2012","unstructured":"Fideleff HL, Jonsson B, Koltowska-Haggstrom M, Boguszewski MC, Wilton P, Boquete HR (2012) GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients. J Pediatr Endocrinol Metab 25(1\u20132):97\u2013105","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"1052_CR111","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1210\/jc.2005-0439","volume":"90","author":"AF Attanasio","year":"2005","unstructured":"Attanasio AF, Shavrikova EP, Blum WF, Shalet SM (2005) Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. J Clin Endocrinol Metab 90(8):4525\u20134529","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1052_CR112","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1210\/jc.2009-2013","volume":"95","author":"M Koltowska-Haggstrom","year":"2010","unstructured":"Koltowska-Haggstrom M, Geffner ME, Jonsson P, Monson JP, Abs R, Hana V et al (2010) Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency. J Clin Endocrinol Metab 95(6):2646\u20132654","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1052_CR113","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1210\/jc.2005-0208","volume":"90","author":"N Mauras","year":"2005","unstructured":"Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B et al (2005) Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 90(7):3946\u20133955","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1052_CR114","first-page":"74","volume":"64","author":"PE Clayton","year":"2005","unstructured":"Clayton PE, Shalet SM (2005) Difficulties in patient management associated with the transition period. Horm Res 64(Suppl 2):74\u201375","journal-title":"Horm Res"},{"issue":"9","key":"1052_CR115","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/BF03343912","volume":"24","author":"SD Chernausek","year":"2001","unstructured":"Chernausek SD (2001) Managing the transition of adolescents with GH deficiency. J Endocrinol Investig 24(9):676\u2013680","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"1052_CR116","first-page":"206","volume":"12","author":"M Doknic","year":"2014","unstructured":"Doknic M, Stojanovic M, Popovic V (2014) Novel long-acting GH preparations. Pediatr Endocrinol Rev 12(2):206\u2013212","journal-title":"Pediatr Endocrinol Rev"},{"issue":"Suppl A","key":"1052_CR117","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.ghir.2004.03.026","volume":"14","author":"C van den Bos","year":"2004","unstructured":"van den Bos C, Heinen RC, Sukel M, van der Pal HJ, Geenen MM (2004) Screening for late effects in survivors of childhood cancer: growth hormone deficiency from a pediatric oncologist\u2019s point of view. Growth Horm IGF Res 14(Suppl A):S125\u2013S128","journal-title":"Growth Horm IGF Res"},{"issue":"Suppl 1","key":"1052_CR118","first-page":"1","volume":"56","author":"PM Stewart","year":"2001","unstructured":"Stewart PM, Toogood AA, Tomlinson JW (2001) Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Horm Res 56(Suppl 1):1\u20136","journal-title":"Horm Res"},{"issue":"7","key":"1052_CR119","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611\u2013629","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1052_CR120","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1210\/jc.2005-1694","volume":"91","author":"SK Paulsen","year":"2006","unstructured":"Paulsen SK, Pedersen SB, Jorgensen JO, Fisker S, Christiansen JS, Flyvbjerg A et al (2006) Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab 91(3):1093\u20131098","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1052_CR121","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2265.2003.01894.x","volume":"59","author":"FM Swords","year":"2003","unstructured":"Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP (2003) The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clin Endocrinol (Oxf) 59(5):613\u2013620","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"1052_CR122","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1210\/jc.2007-0941","volume":"92","author":"MR Martins","year":"2007","unstructured":"Martins MR, Doin FC, Komatsu WR, Barros-Neto TL, Moises VA, Abucham J (2007) Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. J Clin Endocrinol Metab 92(11):4144\u20134153","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1052_CR123","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1172\/JCI29812","volume":"116","author":"AC Bianco","year":"2006","unstructured":"Bianco AC, Kim BW (2006) Deiodinases: implications of the local control of thyroid hormone action. J Clin Investig 116(10):2571\u20132579","journal-title":"J Clin Investig"},{"issue":"2","key":"1052_CR124","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1210\/jcem-45-2-324","volume":"45","author":"T Sato","year":"1977","unstructured":"Sato T, Suzukui Y, Taketani T, Ishiguro K, Masuyama T (1977) Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. J Clin Endocrinol Metab 45(2):324\u2013329","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1052_CR125","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0022-3476(05)81190-4","volume":"121","author":"P Pirazzoli","year":"1992","unstructured":"Pirazzoli P, Cacciari E, Mandini M, Sganga T, Capelli M, Cicognani A et al (1992) Growth and thyroid function in children treated with growth hormone. J Pediatr 121(2):210\u2013213","journal-title":"J Pediatr"},{"issue":"2","key":"1052_CR126","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2265.2000.01071.x","volume":"53","author":"ES Portes","year":"2000","unstructured":"Portes ES, Oliveira JH, MacCagnan P, Abucham J (2000) Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol (Oxf) 53(2):183\u2013189","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1052_CR127","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1046\/j.1365-2265.2003.01892.x","volume":"59","author":"C Giavoli","year":"2003","unstructured":"Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P et al (2003) Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Clin Endocrinol (Oxf) 59(6):806\u2013810","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"1052_CR128","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1055\/s-2005-921104","volume":"37","author":"S Seminara","year":"2005","unstructured":"Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L et al (2005) Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth? Horm Metab Res 37(12):751\u2013756","journal-title":"Horm Metab Res"},{"issue":"1","key":"1052_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/me.2013-1245","volume":"28","author":"D Avtanski","year":"2014","unstructured":"Avtanski D, Novaira HJ, Wu S, Romero CJ, Kineman R, Luque RM et al (2014) Both estrogen receptor alpha and beta stimulate pituitary GH gene expression. Mol Endocrinol 28(1):40\u201352","journal-title":"Mol Endocrinol"},{"issue":"11","key":"1052_CR130","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.1210\/jc.2005-1207","volume":"90","author":"PM Mah","year":"2005","unstructured":"Mah PM, Webster J, Jonsson P, Feldt-Rasmussen U, Koltowska-Haggstrom M, Ross RJ (2005) Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab 90(11):5964\u20135969","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1052_CR131","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1210\/jc.2010-0476","volume":"95","author":"V Birzniece","year":"2010","unstructured":"Birzniece V, Sata A, Sutanto S, Ho KK (2010) Paracrine regulation of growth hormone secretion by estrogen in women. J Clin Endocrinol Metab 95(8):3771\u20133776","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1052_CR132","first-page":"2848","volume":"81","author":"MF Bellantoni","year":"1996","unstructured":"Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR (1996) Effects of oral versus transdermal estrogen on the growth hormone\/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 81(8):2848\u20132853","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1052_CR133","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1073\/pnas.0337600100","volume":"100","author":"KC Leung","year":"2003","unstructured":"Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH et al (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100(3):1016\u20131021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1052_CR134","first-page":"1407","volume":"76","author":"AJ Weissberger","year":"1993","unstructured":"Weissberger AJ, Ho KK (1993) Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 76(6):1407\u20131412","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1052_CR135","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/eje.0.1350211","volume":"135","author":"G Saggese","year":"1996","unstructured":"Saggese G, Cesaretti G, Franchi G, Startari L (1996) Testosterone-induced increase of insulin-like growth factor I levels depends upon normal levels of growth hormone. Eur J Endocrinol 135(2):211\u2013215","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1052_CR136","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0889-8529(05)70200-0","volume":"30","author":"N Mauras","year":"2001","unstructured":"Mauras N (2001) Growth hormone and sex steroids. Interactions in puberty. Endocrinol Metab Clin N Am 30(3):529\u2013544","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"8","key":"1052_CR137","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0026-0495(03)00163-X","volume":"52","author":"N Mauras","year":"2003","unstructured":"Mauras N, Rini A, Welch S, Sager B, Murphy SP (2003) Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism 52(8):964\u2013969","journal-title":"Metabolism"},{"issue":"2","key":"1052_CR138","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1152\/ajpendo.00483.2004","volume":"289","author":"J Gibney","year":"2005","unstructured":"Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK (2005) Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289(2):E266\u2013E271","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"1052_CR139","first-page":"3414","volume":"82","author":"JD Veldhuis","year":"1997","unstructured":"Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B et al (1997) Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82(10):3414\u20133420","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1052_CR140","doi-asserted-by":"publisher","first-page":"568","DOI":"10.7326\/0003-4819-152-9-201005040-00007","volume":"152","author":"U Meinhardt","year":"2010","unstructured":"Meinhardt U, Nelson AE, Hansen JL, Birzniece V, Clifford D, Leung KC et al (2010) The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann Intern Med 152(9):568\u2013577","journal-title":"Ann Intern Med"},{"issue":"1","key":"1052_CR141","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1542\/peds.2009-2802","volume":"126","author":"TO Henderson","year":"2010","unstructured":"Henderson TO, Friedman DL, Meadows AT (2010) Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics 126(1):129\u2013136","journal-title":"Pediatrics"},{"issue":"10 Suppl","key":"1052_CR142","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/cncr.26042","volume":"117","author":"PC Nathan","year":"2011","unstructured":"Nathan PC, Hayes-Lattin B, Sisler JJ, Hudson MM (2011) Critical issues in transition and survivorship for adolescents and young adults with cancers. Cancer 117(10 Suppl):2335\u20132341","journal-title":"Cancer"},{"issue":"4","key":"1052_CR143","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ctrv.2010.02.014","volume":"36","author":"PK Prasad","year":"2010","unstructured":"Prasad PK, Bowles T, Friedman DL (2010) Is there a role for a specialized follow-up clinic for survivors of pediatric cancer? Cancer Treat Rev 36(4):372\u2013376","journal-title":"Cancer Treat Rev"},{"key":"1052_CR144","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2019.2019.0176","author":"JM Wit","year":"2019","unstructured":"Wit JM, Bidlingmaier M, de Bruin C, Oostdijk W (2019) A proposal for the interpretation of the serum IGF-I concentration as part of laboratory screening in children with growth failure. J Clin Res Pediatr Endocrinol. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2019.2019.0176","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"11","key":"1052_CR145","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KCJ Yuen","year":"2019","unstructured":"Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM et al (2019) American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract 25(11):1191\u20131232","journal-title":"Endocr Pract"},{"issue":"3","key":"1052_CR146","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1530\/EC-18-0047","volume":"7","author":"G Johannsson","year":"2018","unstructured":"Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P et al (2018) Growth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocr Connect 7(3):R126\u2013R134","journal-title":"Endocr Connect"},{"key":"1052_CR147","doi-asserted-by":"crossref","unstructured":"Consensus guidelines for the (1998) diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 83(2):379\u2013381","DOI":"10.1210\/jc.83.2.379"},{"issue":"1","key":"1052_CR148","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1210\/jc.2002-021094","volume":"88","author":"KH Darzy","year":"2003","unstructured":"Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 88(1):95\u2013102","journal-title":"J Clin Endocrinol Metab"},{"issue":"8905","key":"1052_CR149","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","volume":"343","author":"DM Hoffman","year":"1994","unstructured":"Hoffman DM, O\u2019Sullivan AJ, Baxter RC, Ho KK (1994) Diagnosis of growth-hormone deficiency in adults. Lancet 343(8905):1064\u20131068","journal-title":"Lancet"},{"issue":"4","key":"1052_CR150","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1365-2265.2003.01739.x","volume":"58","author":"J Donaubauer","year":"2003","unstructured":"Donaubauer J, Kiess W, Kratzsch J, Nowak T, Steinkamp H, Willgerodt H et al (2003) Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clin Endocrinol 58(4):456\u2013463","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1052_CR151","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1365-2265.2005.02272.x","volume":"62","author":"JN Ham","year":"2005","unstructured":"Ham JN, Ginsberg JP, Hendell CD, Moshang T Jr (2005) Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Clin Endocrinol 62(5):628\u2013632","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1052_CR152","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1210\/jc.2005-0304","volume":"90","author":"J Bjork","year":"2005","unstructured":"Bjork J, Link K, Erfurth EM (2005) The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation. J Clin Endocrinol Metab 90(11):6048\u20136054","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1052_CR153","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2265.2007.02842.x","volume":"67","author":"G Radetti","year":"2007","unstructured":"Radetti G, di Iorgi N, Paganini C, Gastaldi R, Napoli F, Lorini R et al (2007) The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. Clin Endocrinol 67(1):78\u201384","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1052_CR154","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1515\/JPEM.2008.21.11.1049","volume":"21","author":"W Bonfig","year":"2008","unstructured":"Bonfig W, Bechtold S, Bachmann S, Putzker S, Fuchs O, Pagel P et al (2008) Reassessment of the optimal growth hormone cut-off level in insulin tolerance testing for growth hormone secretion in patients with childhood-onset growth hormone deficiency during transition to adulthood. J Pediatr Endocrinol Metab 21(11):1049\u20131056","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"1052_CR155","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1530\/EJE-13-0572","volume":"169","author":"C Courtillot","year":"2013","unstructured":"Courtillot C, Baudoin R, Du Souich T, Saatdjian L, Tejedor I, Pinto G et al (2013) Monocentric study of 112 consecutive patients with childhood onset GH deficiency around and after transition. Eur J Endocrinol 169(5):587\u2013596","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1052_CR156","first-page":"3990","volume":"85","author":"Growth Hormone Research Society","year":"2000","unstructured":"Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85(11):3990\u20133993","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1052_CR157","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1530\/EJE-07-0384","volume":"157","author":"G Corneli","year":"2007","unstructured":"Corneli G, Di Somma C, Prodam F, Bellone J, Bellone S, Gasco V et al (2007) Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol 157(6):701\u2013708","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-020-01052-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:10:47Z","timestamp":1722982247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-020-01052-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01052-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"3 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Emilia Sbardella, Marco Crocco, Tiziana Feola, Fortuna Papa, Giulia Puliani, Daniele Gianfrilli, Andrea M. Isidori and Ashley B. Grossman have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}